Menu
Back to User profile » Dr Janet E Olson
Papers published by Dr Janet E Olson:
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
Takahashi PY, Ryu E, Cerhan JR, Bielinski SJ, Olson JE
Pharmacogenomics and Personalized Medicine 2021, 14:545-546
Published Date: 6 May 2021
No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study
Takahashi PY, Ryu E, Bielinski SJ, Hathcock M, Jenkins GD, Cerhan JR, Olson JE
Pharmacogenomics and Personalized Medicine 2021, 14:229-237
Published Date: 11 February 2021
Association of mitochondrial DNA copy number with self-rated health status
Takahashi PY, Jenkins GD, Welkie BP, McDonnell SK, Evans JM, Cerhan JR, Olson JE, Thibodeau SN, Cicek MS, Ryu E
The Application of Clinical Genetics 2018, 11:121-127
Published Date: 25 October 2018
CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications
St Sauver JL, Olson JE, Roger VL, Nicholson WT, Black III JL, Takahashi PY, Caraballo PJ, Bell EJ, Jacobson DJ, Larson NB, Bielinski SJ
Pharmacogenomics and Personalized Medicine 2017, 10:217-227
Published Date: 24 July 2017
Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6
Takahashi PY, Ryu E, Pathak J, Jenkins GD, Batzler A, Hathcock MA, Black JL, Olson JE, Cerhan JR, Bielinski SJ
Pharmacogenomics and Personalized Medicine 2017, 10:39-47
Published Date: 14 February 2017
Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank
Takahashi PY, Ryu E, Olson JE, Winkler EM, Hathcock MA, Gupta R, Sloan JA, Pathak J, Bielinski SJ, Cerhan JR
International Journal of General Medicine 2015, 8:247-254
Published Date: 11 August 2015